|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03309 C-MER MEDICAL
Nominal 
1.480 0.000 (0.000%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | -4.943% | 2.194% | -0.901% | 1.220% | -0.454% |
| ROAE (%) | -7.512% | 3.341% | -1.368% | 1.665% | -0.581% |
| Return on Capital Employed (%) | -5.851% | 2.628% | -0.920% | 1.413% | -0.423% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 27.578% | 32.171% | 25.850% | 32.198% | 27.743% |
| EBITDA Margin (%) | 7.708% | 17.689% | 10.829% | 15.579% | 17.388% |
| Pre-tax Profit Margin (%) | -3.984% | 6.459% | -0.648% | 2.416% | 0.358% |
| Net Profit Margin (%) | -7.065% | 3.222% | -1.263% | 1.965% | -0.893% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 1.562 X | 1.850 X | 1.632 X | 1.828 X | 4.013 X |
| Quick Ratio (X) | 1.447 X | 1.750 X | 1.534 X | 1.746 X | 3.879 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 30.522% | 27.481% | 31.135% | 31.629% | 20.377% |
| Total Debt / Total Assets (%) | 16.094% | 13.206% | 15.594% | 24.117% | 15.036% |
| Net Debt / Total Assets (%) | 0.541% | -5.449% | -6.624% | 4.348% | -18.964% |
| Total Debt / Shareholders' Funds (%) | 24.978% | 19.666% | 24.248% | 35.433% | 18.926% |
| Long Term Debt / Shareholders' Funds (%) | 17.042% | 13.352% | 16.246% | 15.490% | 13.704% |
| Net Debt / Shareholders' Funds (%) | 0.839% | -8.114% | -10.300% | 6.387% | -23.871% |
| Net Cash / (Debt) ($) | (14.708M) | 149.772M | 192.211M | (85.032M) | 308.969M |
| Net Cash / (Debt) per share ($) | (0.012) | 0.119 | 0.152 | (0.074) | 0.269 |
| Total Debt / Capital Employed (%) | 18.951% | 15.385% | 19.037% | 30.478% | 16.586% |
| Interest Coverage Ratio (X) | N/A | 7.857 X | 0.429 X | 3.068 X | 1.242 X |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 11.340 Day | 12.618 Day | 12.054 Day | 13.037 Day | 12.497 Day |
| Receivables Turnover (Day) | 10.601 Day | 9.533 Day | 6.861 Day | 5.369 Day | 6.777 Day |
| Payables Turnover (Day) | 10.562 Day | 9.507 Day | 8.975 Day | 9.660 Day | 8.576 Day |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -135,163 |
| %Change | -- |
| EPS / (LPS) | HKD -0.110 |
| NBV Per Share ($) | HKD 1.396 |